Histogenics Investors

15 investors on Angel Roster list Histogenics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Histogenics can appear together.

Investors listed
15
With verified email
47%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Histogenics investors

The most complete profiles first. Showing 15 of 15.

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alex RayVerified

    Private Equity Firm · United States

    Health CareWellnessLife ScienceArtificial Intelligence (AI)

    Portfolio: PhotonEx, Rejuvenon, iParty, Novalar Pharmaceuticals and 56 more

    Verified email available

  • Frank SilvaVerified

    Private Equity Firm · United States

    Health CareWellnessLife ScienceArtificial Intelligence (AI)

    Portfolio: PhotonEx, Rejuvenon, iParty, Novalar Pharmaceuticals and 56 more

    Contact details available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Rob ShermanVerified

    Private Equity Firm · United States

    Health CareWellnessLife ScienceArtificial Intelligence (AI)

    Portfolio: PhotonEx, Rejuvenon, iParty, Novalar Pharmaceuticals and 56 more

    Verified email available

  • Dana Callow

    Venture Capital, Private Equity Firm, Micro VC · United States

    CrowdfundingHealth CareWellnessLife ScienceArtificial Intelligence (AI)

    Portfolio: PhotonEx, Rejuvenon, iParty, Novalar Pharmaceuticals and 56 more

    Contact details available

  • Elizabeth Callow

    Venture Capital, Private Equity Firm, Micro VC · United States

    CrowdfundingHealth CareWellnessLife ScienceArtificial Intelligence (AI)

    Portfolio: PhotonEx, Rejuvenon, iParty, Novalar Pharmaceuticals and 56 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Marty Hernon

    Private Equity Firm · United States

    Health CareWellnessLife ScienceArtificial Intelligence (AI)

    Portfolio: PhotonEx, Rejuvenon, iParty, Novalar Pharmaceuticals and 56 more

    Contact details available

Frequently asked questions

How many Histogenics investors are on Angel Roster?

Angel Roster lists 15 Histogenics investors. 7 of them (47%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (11), Private Equity Firms (6) and Micro VC Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Histogenics investors invest in?

Among those that list a stage, the most common are Seed (4), Crowdfunding (2) and Series B (1).

Where are Histogenics investors based?

Most are based in the United States (14) and Canada (1).

Which companies have Histogenics investors backed?

The most-backed portfolio companies among them are Principia Biopharma (9), Versartis (9), NuCana (9), Mirna Therapeutics (9) and ObsEva (9).

How do I contact Histogenics investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.